VKTX
VKTX
NASDAQ · Biotechnology

Viking Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$31.33
-0.25 (-0.79%)
As of May 9, 1:24 AM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +117.7% upside
Low Target $46.84
Average Target $68.21
High Target $80.11
Current Price $31.33
Current
$31.33
Target
$68.21
$46.84 $68.21 avg $80.11
Scenario Analysis
Bear Case
$46.84
49.5%
Low target
Base Case
$68.21
+117.7%
Avg target
Bull Case
$80.11
+155.7%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$43.15
-27.4% from high
52-Week Low
$22.96
+36.5% from low
50-Day SMA
$32.83
-4.6% vs SMA
200-Day SMA
$31.34
0.0% vs SMA
RSI (14)
52.7
Neutral
Target vs 52W High
$68.21
+58.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 72% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 26 96% $143.40 +41.5%